Clarity Medical Reports Stable Share Capital Structure for August 2026

Bulletin Express09-03

Clarity Medical Group Holding Limited reported no changes to its share capital during August 2026. Authorised share capital remained at 5.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 50.00 million. Issued shares were steady at 539.77 million, and the company held no treasury shares.

Management confirmed compliance with the Hong Kong Stock Exchange’s minimum 25 percent public-float requirement as at 31 August 2026.

There were no share issuances, cancellations, repurchases, or transfers during the month. The Pre-IPO share option scheme had zero options outstanding or exercisable, and no new options were granted. Under the existing share award plan, the company may issue up to 40.54 million shares, but none were granted or vested in August.

The unchanged capital base combined with confirmed float sufficiency indicates that Clarity Medical’s equity structure remained stable throughout the reporting period, with no dilution to existing shareholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment